{"id":"W4389203459","doi":"10.3390/curroncol30120743","title":"Sequencing Antibody Drug Conjugates in Breast Cancer: Exploring Future Roles","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Trastuzumab emtansine; Trastuzumab; Breast cancer; Antibody-drug conjugate; Adverse effect; Clinical trial; Pertuzumab; Oncology; Cancer; Metastatic breast cancer; Human Epidermal Growth Factor Receptor 2; Internal medicine; Immunology; Antibody; Monoclonal antibody","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006344663,0.0001764655,0.0004638248,0.0004191157,0.00007407039,0.0000167127,0.000189247,0.0001054954,0.00036107],"category_scores_gemma":[0.0000654843,0.0001592493,0.00007205645,0.0008785864,0.0001253025,0.0001158985,0.0001583032,0.0007756172,0.0002484126],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001398476,"about_ca_system_score_gemma":0.001126584,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003610545,"about_ca_topic_score_gemma":0.0006114952,"domain_scores_codex":[0.998051,0.0001511311,0.0003376951,0.0004210932,0.0003493705,0.0006896686],"domain_scores_gemma":[0.9991653,0.0001520644,0.00006459136,0.0002706706,0.0001363428,0.0002110419],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000213444,0.0001737014,0.6389731,0.0007286856,0.00004289323,0.0005544359,0.00418663,0.0000776303,0.01436303,0.0002423342,0.01857577,0.3218683],"study_design_scores_gemma":[0.004435367,0.0003103648,0.3698931,0.002206468,0.00007003638,0.0002727183,0.01221537,0.003045882,0.004049898,0.0002622799,0.6027434,0.0004951506],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9727059,0.005519159,0.000003174307,0.0170693,0.00318713,0.0004339847,0.00005100658,0.0002022734,0.0008280585],"genre_scores_gemma":[0.9678739,0.02821209,0.00004070658,0.0001855037,0.002867999,0.0004847212,0.00009486592,0.00005079577,0.0001894573],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5841676,"threshold_uncertainty_score":0.6493996,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2340140714763621,"score_gpt":0.4955780024025366,"score_spread":0.2615639309261746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}